CLEAR CELL RENAL CARCINOMA
Clinical trials for CLEAR CELL RENAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: ivonescimab trial launches
Disease control Recruiting nowThis Phase 2 trial tests the drug ivonescimab in 40 people with advanced clear cell renal cell carcinoma that has worsened after prior treatment. The goal is to see if the drug can help control the cancer and to monitor any side effects. Participants receive ivonescimab by IV inf…
Matched conditions: CLEAR CELL RENAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for kidney cancer patients with bone spread: drug combo trial launches
Disease control Recruiting nowThis phase 2 trial tests a new drug called zanzalintinib, taken as a pill, combined with a bone-strengthening agent for people with advanced kidney cancer that has spread to the bones. The study enrolls 20 participants whose cancer has worsened after 1–3 prior treatments, includi…
Matched conditions: CLEAR CELL RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Cancer-Killing virus trial launches for patients out of options
Disease control Recruiting nowThis study tests a new treatment called GO306, a modified virus designed to infect and destroy cancer cells. It is for adults with advanced solid tumors (like breast, colon, or kidney cancer) that have not responded to standard therapies. The main goal is to check the safety of t…
Matched conditions: CLEAR CELL RENAL CARCINOMA
Phase: PHASE1 • Sponsor: GeneSail Biotech (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC